Amarin Corp Plc (AMRN)

[lettruthringout]

"Poisonous troll" breaks AHA embargo.

https://www.investorvillage.com/uploads/87669/files/AHA-scientific-statement.pdf

"In patients with diabetes and ASCVD or patients with diabetes at high risk for ASCVD with serum triglycerides of 135 to 500 mg/dL despite maximally tolerated statin, and addressing contributory factors including lifestyle modification prescription icosapent ethyl at a dose of 4 g/d, as well, should be considered given the 30% additional cardiovascular risk reduction in the REDUCE-IT trial (Reduction of Cardiovascular Events With Icosapent Ethyl–Intervention Trial). Of note, the median baseline LDL-C in this trial was 75 mg/dL, and 29% of the study population had diabetes."